Skip to main content
The Cochrane Database of Systematic Reviews logoLink to The Cochrane Database of Systematic Reviews
. 2011 Jan 19;2011(1):CD005660. doi: 10.1002/14651858.CD005660.pub3

Analgesia in patients with acute abdominal pain

Carlos Manterola 1,, Manuel Vial 1, Javier Moraga 1, Paula Astudillo 1
Editor: Cochrane Colorectal Cancer Group
PMCID: PMC12296243  PMID: 21249672

Abstract

Background

For decades, the indication of analgesia in patients with Acute Abdominal Pain (AAP) has been deferred until the definitive diagnosis has been made, for fear of masking symptoms, generating a change in the physical exploration or obstructing the diagnosis of a disease requiring surgical treatment. This strategy has been questioned by some studies that have shown that the use of analgesia in the initial evaluation of patients with AAP leads to a significant reduction in pain without affecting diagnostic accuracy.

Objectives

To determine whether the evidence available supports the use of opioid analgesics in the diagnostic process of patients with AAP.

Search methods

Trials were identified through searches in Cochrane Controlled Trials Register (CENTRAL) (The Cochrane Library, issue 2, 2009), MEDLINE (1966 to 2009) and EMBASE (1980 to 2009). A randomised controlled trial (RCT) filter for a MEDLINE search was applied (with appropriate modification for an EMBASE search). Trials also were identified through "related articles". The search was not limited by language or publication status.

Selection criteria

All published RCTs which included adult patients with AAP, without gender restriction, comparing any opioids analgesia regimen with the non‐use of analgesic before any intervention and independent of the results.

Data collection and analysis

Two independent reviewers assessed the studies identified via the electronic search. Articles that were relevant and pertinent to the aims of the study were selected and their respective full‐text versions were collected for subsequent blinded evaluation. The allocation concealment was considered in particular as an option to diminish the biases.

The data collected from the studies were reviewed qualitatively and quantitatively using the Cochrane Collaboration statistical software RevMan 5.0. After performing the meta‐analysis, the chi‐squared test for heterogeneity was applied. In situations of significant clinical heterogeneity, statistical analyses were not applied to the pool of results. In situations of heterogeneity, the random effect model was used to perform the meta‐analysis of the results. A sensitivity analysis was also applied based on the evaluation to the methodological quality of the primary studies.

Main results

Eight studies fulfilled the inclusion criteria. Differences with use of opioid analgesia were verified in variables: Change in the intensity of the pain, change in the patients comfort level.

Authors' conclusions

The use of opioid analgesics in the therapeutic diagnosis of patients with AAP does not increase the risk of diagnosis error or the risk of error in making decisions regarding treatment.

Keywords: Adult; Humans; Analgesics, Opioid; Abdominal Pain; Abdominal Pain/diagnosis; Abdominal Pain/drug therapy; Acute Disease; Analgesia; Analgesia/methods; Randomized Controlled Trials as Topic

Plain language summary

The use of analgesia for acute abdominal pain (AAP) does not mask clinical findings, nor does it delay diagnosis.

The use of analgesia for AAP does not mask clinical findings nor does it delay diagnosis.

Surgeons are reluctant to use analgesics during the diagnostic process and clinical evaluation of patients with AAP where there may be the possible requirement of surgical intervention. Generally, the fear is that analgesia can mask clinical findings and cause a delay in the diagnosis. Some reports suggest that the use of opioid analgesics in patients with AAP is not associated with masking the clinical picture or delaying the diagnosis.

Hence the research question of this review is: Does available evidence support the use of opioid analgesics in patients with AAP during the diagnostic process?

The aim of this review is to determine whether the evidence available to date supports the use of opioid analgesics in patients with AAP during the diagnostic process.

Clinical trials were performed, in which the use of any analgesic regime with opioids was compared to a placebo administered in the diagnosis process prior to decision‐making in adult subjects with AAP, with no limitation on gender. The valued outcomes were: change in the intensity of the pain, change in the patient’s comfort level, time necessary to formulate diagnosis, time necessary to operate (in the applicable cases), rate of correct decision‐making, error rate in the treatment undertaken, hospital stay and morbidity.

Background

Acute abdominal pain (AAP) is a common cause for consultation in emergency departments (ED). It is one of the top three symptoms for which patients go to the ED, and represents between 5% and 10% of all the illnesses treated in the ED (Stone 1998). The most common causes of acute abdominal pain are appendicitis, cholecystitis, intestinal obstruction, urinary colic, gastritis, perforated peptic ulcer, gastroenteritis, pancreatitis, diverticulitis, gynaecological disorders in women and non‐surgical abdominal pain (Ahn 2002). The diagnostic options that permit differentiation between serious and less serious acute abdominal problems are clinical history, physical exploration and the results of general laboratory tests (Mahler 2004).

For decades, the indication of analgesia in patients with AAP has been considered prohibited, or it has been deferred at least until establishing the definitive diagnosis for fear of masking symptoms, generating a change in the physical exploration or obstructing the diagnostic process of a surgically treatable disease.

There are several relevant obstacles to determining the appropriate use of analgesia in patients with AAP. The most important are: lack of adequate evidence‐based data, contradiction between the perception of the pain on the part of the doctors and their patients, and concern over a misdiagnosis once the patients with abdominal pain receive an analgesic (Gallagher 2002; McHale 2001). Many surgeons make it standard clinical practice to not use analgesics prior to the valuation and decision regarding surgery in patients with AAP because they think the analgesia could make the evaluation and diagnostic accuracy difficult (Kim 2003).

This non‐evidence‐based approach has been questioned by some analgesic work groups who have shown that the use of analgesics in the diagnostic process of patients with AAP leads to a significant reduction in pain without affecting diagnostic accuracy (Kim 2003; Thomas 2003a).

Despite advances in the knowledge of physiology and progress in the treatment of pain, the use of analgesics in the diagnostic process of patients with AAP is not considered a conventional treatment. Some studies suggest a fast and effective analgesia does not interfere with the diagnosis in patients with acute abdomen; indeed, it may even facilitate the initial physical exploration. This is a matter in which, moreover, several analgesic regimes have been used (Camus‐Kerebel 1996; Thomas 2003;Thomas 2003a). While this controversy surrounds the ED, only a few studies have broached the level of doctor‐patient agreement regarding the intensity of the abdominal pain and the need for analgesia (Attard 1992; Kim 2003; McHale 2001;Thomas 1999).

In addition, the early administration of analgesics in patients with AAP can reduce the pain considerably; in fact, it does not interfere with the diagnosis and may even facilitate it despite the reduction in the intensity of the symptoms (Attard 1992).

This research proposes that it is humane and safe to administer pharmacological pain relief to patients who arrive at the ED with AAP as long as there are no contraindications (McHale 2001). This review examined the currently available evidence that supports opioid analgesic use or non‐use in the diagnostic process of patients with AAP.

Objectives

The principal objective is to determine if the evidence currently available supports the use of opioid analgesics in the diagnostic process of patients with AAP.

The secondary objective is to evaluate the changes in the patient’s comfort level while the diagnosis is established and the treatment strategy is definitively ascertained.

Methods

Criteria for considering studies for this review

Types of studies

All published randomised controlled trials comparing any opioid analgesia regime to no analgesia administered before any intervention regardless of the outcomes examined.

Types of participants

Patients over the age of 16 with AAP, without gender restriction.

Types of interventions

Non‐use versus use of any type of opioid analgesia.

Types of outcome measures

Primary measure: 
 Rate of accurate management decisions.

Secondary measures:

Change in the intensity of the pain

Change in the patient’s comfort level

Changes in the physical exploration

Error in making decisions about treatment

Incorrect diagnosis

Morbidity

Hospital stay

Search methods for identification of studies

The Trials were identified using searches in the Cochrane Controlled Trials Register (CENTRAL) (The Cochrane Library, issue 2, 2009), MEDLINE (1966 to present) and EMBASE (1980 to present). A randomised controlled trial filter for a MEDLINE search was applied (with appropriate modification for EMBASE search).

Search Strategy:

#1: Appendicitis[MeSH]

#2: Abdominal Pain [MeSH]

#3: Abdomen, Acute [MeSH]

#4: Analgesia [MeSH]

#5: Analgesics [MeSH]

#6: Analgesics, Non‐Narcotic [MeSH

#7: Analgesics, Opiod [MeSH]

#8: Anti‐Inflammatory Agents, Non‐Steroidal [MeSH]

#9: ("Appendicitis/diagnosis"[MeSH]) OR ("Appendicitis/surgery"[MeSH]) OR ("Abdominal Pain/diagnosis"[MeSH]) OR ("Abdominal Pain/etiology"[MeSH]) OR ("Abdominal Pain/surgery"[MeSH]) OR ("Abdomen, Acute/diagnosis"[MeSH]) OR ("Abdomen, Acute/surgery"[MeSH]) OR ("Abdomen, Acute/etiology"[MeSH])

#10: ("Appendicitis/diagnosis"[MeSH] AND "Analgesics"[MeSH] ) OR ("Abdominal Pain/diagnosis"[MeSH] AND "Analgesics"[MeSH] ) OR ("Abdominal Pain/etiology"[MeSH] AND "Analgesics"[MeSH] ) OR ("Abdominal Pain/surgery"[MeSH] AND "Analgesics"[MeSH]) OR ("Appendicitis/surgery"[MeSH] AND "Analgesics"[MeSH]) OR ("Abdomen, Acute/diagnosis"[MeSH] AND "Analgesics"[MeSH]) OR ("Abdomen, Acute/surgery"[MeSH] AND "Analgesics"[MeSH]) OR ("Abdomen, Acute/etiology"[MeSH] AND "Analgesics"[MeSH])

#11: ("Appendicitis/diagnosis"[MeSH] AND "Analgesia"[MeSH] ) OR ("Abdominal Pain/diagnosis"[MeSH] AND "Analgesia"[MeSH] ) OR ("Abdominal Pain/etiology"[MeSH] AND "Analgesia"[MeSH] ) OR ("Abdominal Pain/surgery"[MeSH] AND "Analgesia"[MeSH]) OR ("Appendicitis/surgery"[MeSH] AND "Analgesia"[MeSH]) OR ("Abdomen, Acute/diagnosis"[MeSH] AND "Analgesia"[MeSH]) OR ("Abdomen, Acute/surgery"[MeSH] AND "Analgesia"[MeSH]) OR ("Abdomen, Acute/etiology"[MeSH] AND "Analgesia"[MeSH])

#12: #9 OR #10 OR #11 Limits: Clinical Trial, Humans, only items with available abstracts.

Trials were also identified using "related articles".

The search was not limited by language or publication status.

Data collection and analysis

Trial Selection 
 From the result of the electronic searches, two independent reviewers selected the studies with the inclusion criteria using a checklist designed in advance for that purpose. The discrepancies were solved by consensus.

Trial Identification 
 Two reviewers (CM, MV) independently evaluated the titles and abstracts of reports identified through the electronic search. Potentially relevant studies selected by at least one reviewer were retrieved in full text versions to be evaluated for valuation and subsequent inclusion.

Data Extraction 
 A specific page was generated of the data collected. Two reviewers extracted the data relating to the design type of the studies included, the participants, the analgesic regime used (drugs, dose and tracts of administration), the method of random allocation (patient characteristics and numbers), the exclusion criteria after the process of random allocation, the masking of the patients and/or the observers; and the outcome measures described previously.

Quality Assessment

The studies were blinded (the authors and institutions were deleted and the results section removed) to the reviewers. The checklist for the quality of the de randomised controlled trials included: concealment of the allocation sequence, generation of the allocation sequence, comparability between groups at the baseline and inclusion of all randomised participants in the analysis. Allocation concealment is regarded as particularly important in protecting against bias and was graded using the Cochrane approach as follows:

Grade A: Clearly adequate concealment

Grade B: Possibly adequate concealment

Grade C: Clearly inadequate concealment

Data Analysis

The data set was generated as completely as possible. The data from the primary studies included were reviewed qualitatively and quantitatively using the Cochrane Collaborations´ statistical software RevMan Analysis 5.0.

The quantitative analysis of outcomes was based on intention‐to‐treat results. In the case of an existing clinically significant heterogeneity, statistical analyses were not applied to the results. After to meta‐analysis, a heterogeneity chi‐squared test was applied. In cases of heterogeneity, the random effects model was used to meta‐analyse the results.

Then a sensitivity analysis was applied based on quality assessment.  

Results

Description of studies

Attard 1992.

Randomised double‐blind controlled trial with allocation concealment unclear, conducted at Walsgrave Hospital, Coventry. 100 consecutive patients over 16 years of age with clinically significant abdominal pain of less than 48 hours’ evolution who were admitted as emergencies to a surgical firm. In the study, subjects were randomised to intramuscular injection of up to 20 mg papaveretum or an equivalent volume of saline (50 patients to each group). Outcome measures considered were pain and tenderness scores, assessment of patient comfort, accuracy of diagnosis and management decisions. Median pain and tenderness scores were lower after papaveretum. Incorrect diagnoses and management decisions applied to 2/50 patients after papaveretum compared with 9/50 patients after saline solution injection.

Pace 1996.

Randomized double‐blind controlled trial with adequate allocation concealment, conducted at Madigan Army Medical Center, Fort Lewis. Seventy‐one patients over 18 years of age abdominal pain for = 48 hours evolution were admitted. In the study, subjects were randomised to morphine (10 mg) or placebo (normal saline made up to an equal volume); 35 patients received morphine and 36 received placebo. Outcome measures considered were pain response using VAS and diagnosis accuracy. The VAS pain level improved more for the morphine group and there was no difference between the groups when comparing accuracy of provisional or differential diagnosis with that of final diagnosis. 

LoVecchio 1997.

Randomized double‐blind controlled trial with adequate allocation concealment, conducted at Good Samaritan Regional Medical Center, Phoenix, Arizona. Forty‐eight patients over 18 years with acute abdominal pain were admitted to the emergency department. In study subjects were randomised to intravenous injection of morphine (5‐10 mg) or placebo (normal saline made up to an equal volume). Outcome measures considered were changes in physical examination, adverse events, localization and tenderness and pain measure by visual analogue scale (VAS). A statistically significant change in physical examination was noted in both groups receiving analgesics, but not in the placebo group. No adverse events or delays in diagnosis were attributed to the administration of analgesics. 

Vermeulen 1999.

Randomized double‐blind controlled trial with allocation concealment unclear, conducted at Hopitaux Universitaires de Geneve, Switzerland. 340 patients over 16 years of age who consulted the emergency department for pain in the right lower part of the abdomen were considered. In the study, subjects were randomised to morphine (10 mg) or placebo (normal saline made up to an equal volume); 175 patients received morphine and 165 received placebo. Outcome measures considered were VAS pain level, final diagnosis, diagnostic accuracy, appropriateness of the decision to operate. Pain relief was stronger in the morphine group; among female patients, the decision to operate was appropriate more often in the morphine group; and, in male patients and overall, opioid analgesia did not influence the appropriateness of the decision. 

Mahadevan 2000.

Randomized double‐blind controlled trial with adequate allocation concealment, conducted at National University Hospital, Singapore. Sixty‐six patients over 16 years with right lower quadrant pain of less than a week's duration (non‐traumatic in origin) suggestive of acute appendicitis were admitted. In the study, subjects were randomised to Tramadol (1 mg/Kg) or placebo (normal saline made up to an equal volume); 33 patients to each group. Outcome measures considered were absence or presence of seven abdominal signs (tenderness on light and deep palpation, tenderness in the right lower quadrant and elsewhere, rebound, cough, and percussion tenderness) and pain measured by VAS at 0 and 30 minutes. There was significant reduction in mean VAS in the analgesic group versus in the placebo group. The analgesic group had less normalization of signs. 

Thomas 2003.

Randomized double‐blind controlled trial with adequate allocation concealment, conducted at Massachusetts General Hospital, Boston. Seventy‐four patients over 18 years of age with undifferentiated abdominal pain of less than 72 hours’ duration were considered. In the study, subjects were randomised to receive placebo (n = 36) or morphine sulphate (n = 38). Outcome measures considered were VAS pain level, changes in diagnostic signs and diagnostic accuracy. There were no differences in physical or diagnostic accuracy between groups; and correlation with clinical course and final diagnosis revealed no instance of masking of physical examination findings. 

Gallagher 2006.

Randomized double‐blind controlled trial with adequate allocation concealment, conducted at Montefiore Medical Center, Bronx, New York, USA. 160 consecutive patients over 21 years of age with atraumatic abdominal pain of less than 48 hours’ duration were enrolled in the study, of whom 153 were available for analysis. 78 were allocated to receive morphine and 75 to receive placebo. In the study, subjects were randomised to receive 0.1 mg/kg morphine sulphate or placebo. Outcome measure considered was clinically important diagnostic accuracy. The median decrease in VAS score at 15 minutes was 33 mm in the morphine group and 2 mm in the placebo group. There were 11 instances of diagnostic discrepancy in each group, for a clinically important diagnostic accuracy of 86% (67/78) in the morphine group and 85% (64/75) in the placebo group. The difference in clinically important diagnostic accuracy between the 2 groups was 1% (95% confidence interval [CI] ‐11% to 12%). Analysis by efficacy and intention to treat yielded similar results. Kappa for interobserver concordance in classification of clinically important diagnostic accuracy was 0.94 (95% CI 0.79 to 1.00). No patients required naloxone. 

Amoli 2008.

Randomized double‐blind controlled trial with adequate allocation concealment, conducted at Sina Hospital, Teheran, Iran. 71 consecutive patients over 14 years with clinically significant abdominal pain were enrolled in the study, 35 were allocated to receive morphine and 36 to receive placebo. In the study, subjects were randomised to receive 0.1 mg/kg morphine sulphate or saline (0.9%) to a maximum dose of 10 mg over a 5 min period. Outcome measures considered were pain intensity using a visual analogue scale (VAS) and signs of acute appendicitis. A more favorable change in VAS score was reported in the morphine group with a significantly greater reduction in the median VAS score than in the placebo group. In 76.7% of patients in the morphine group, appendicitis was confirmed vs. 71.4% of the placebo group. Morphine administration did not cause significant changes in patients' signs or in the physicians' plans or diagnoses. No adverse events were seen in either group.

Summary of included trials.

In summary, eight studies were selected for this systematic review. All of them published in English. The aim of these studies was to compare the use of opioid analgesia (477 patients) versus placebo (446 patients) in patients with AAP. Six trials use morphine sulphate, one study used tramadol, and the other study papaveretum. The inclusion criteria were the same for all studies: patients over 14 years old with non‐traumatic AAP, less than a weeks duration, without gender restriction. Few outcome measures were analysed: changes in physical examination, pain measured by VAS (basal and after intervention), adverse events, final diagnosis, diagnostic accuracy, management decisions.

Risk of bias in included studies

The methodological quality of the studies found was evaluated using the Jadad scale, analysing whether the treatment allocation was random, if the method used was appropriate, if there was double blinding and whether this was appropriate and if losses and drop‐outs were mentioned. Two studies resulted in a point score of 5 on the Jadad 1996 scale (Gallagher 2006 and Amoli 2008), two studies scored 4 points (LoVecchio 1997 and Pace 1996), three studies scored 3 points (Attard 1992, Thomas 2003  and Vermeulen 1999) and one study scored 2 points (Mahadevan 2000).

Effects of interventions

Eight studies fulfilled the inclusion criteria. The sample is made up of 922 patients, 475 in an opioid treatment group and 447 in a placebo group. The eight clinical trials evaluated the use of opioids compared with a saline solution administered in equivalent volume and in the same manner; six of them used morphine in a dose of 5 to 15 mg with a total of 392 subjects in the treatment group (Pace 1996, LoVecchio 1997, Vermeulen 1999, Thomas 2003, Gallagher 2006 and Amoli 2008); one study used Tramadol in a dose of 1mg/kg with a total of 33 subjects in the treatment group (Mahadevan 2000) and one study used papaveretum in a dose of 20 mg with a total of 50 subjects (Attard 1992). In all the studies, the groups were comparable with respect to the intensity of pain prior to the administration of the therapies under study (Analysis 01:01: WMD 0.12, 95% CI [‐0.01, 0.26]). When analysing by subgroups of drugs (Analysis 01:02), no significant differences were found in relation to the intensity of pain measured by VAS among those subjects that received morphine (WMD 0.10, 95% CI [‐0.04, 0.24]) versus those that received tramadol (WMD 0.68, 95% CI [‐0.04, 1.40]) or papaveretum (WMD 0.20, 95% CI [‐0.65, 1.05]). The studies were combined by means of a random effects model given that there was statistical heterogeneity.

Change in the intensity of pain (Analysis 01:05) 
 The 8 trials registered the intensity of post‐treatment pain as a measure of the result, reported using VAS. The grouping of the results showed that in 7 studies the intensity of the pain decreased significantly with the use of opioid analgesics (Amoli 2008, Gallagher 2006, LoVecchio 1997, Pace 1996, Thomas 2003, Vermeulen 1999 and Attard 1992) in patients with AAP (grouped WMD ‐1.94, 95% CI [‐2.92, ‐0.95]). Only Mahadevan 2000 did not demonstrate any benefit in the reduction of pain (WMD ‐0.09, 95% CI [‐0.81, 0.63]).When analysing by subgroups of drugs, it was observed that those patients that received morphine (WMD ‐1.78, 95% CI [‐2.62, ‐0.95]) and papaveretum (WMD ‐5.20, 95% CI [‐6.91, ‐3.49])had a significant reduction in pain compared to those that received tramadol (WMD ‐0.09, 95% CI [‐0.81, 0.63]). In spite of this, statistical heterogeneity can be seen in the sample, which can be influenced by the type of patient included (age and gender) as well as the pharmacological aspects (dosage and type of drug used).

Change in patient’s comfort level (Analysis 01:03; 01:04) 
 With respect to patient comfort, there are only two studies that report on it and in both there is significant improvement of this variable for the group of patients treated with opioid analgesics:Attard 1992 with RR 0.05 [95% CI 0.01, 0.19] and LoVecchio 1997 with WMD ‐2.10, 95% CI [‐3.00, ‐1.20].

Changes in the physical exploration (Analysis 01:06) 
 With respect to changes in the physical examination, this variable was reported in only 5 studies (Amoli 2008, LoVecchio 1997, Pace 1996, Thomas 2003 and Mahadevan 2000). There were no significant differences among the groups in the comparison or when comparing them by drug (RR 1.32 [95% CI 0.67, 2.59]).

Errors in making decision about treatment (Analysis 01:07; 01:08) 
 The variable of error in treatment decision‐making is reported in 3 studies (Attard 1992; LoVecchio 1997; Vermeulen 1999) with no differences being found among the groups in comparison nor when comparing them by drug (RR 0.77 [95% CI 0.23, 2.54]).

Incorrect diagnosis (Analysis 01:09; 01:10) 
 This variable was reported in 6 studies (Attard 1992, Gallagher 2006, LoVecchio 1997,Pace 1996, Thomas 2003, Vermeulen 1999); no significant differences were found among the groups in the study (RR 0.81 [95% CI 0.48, 1.37]). When analysing by subgroups of active ingredient, it was observed in Attard 1992 that the group that received papaveretum had a lower proportion of patients with an incorrect diagnosis than the placebo group (RR 0.22 [95% CI 0.05, 0.98]).

Morbidity (Analysis 01:11) 
 The adverse effects reported in 4 studies (Amoli 2008, Pace 1996, Vermeulen 1999, Attard 1992) were nausea and vomiting. In relation to this variable, no statistically significant differences can be seen among the groups in the comparison nor when comparing by drug (RR 5.14 [95% CI 0.26, 103.37]).

Lenght of Hospital stay (Analysis 01:12) 
 This variable was only reported in Attard 1992, with no statistically significant differences found among the groups being compared (WMD ‐1.00, 95% CI [‐1.52, ‐0.48]).

Accurate management decisions (Analysis 01:13) 
 This variable was only reported in 3 studies (LoVecchio 1997, Vermeulen 1999, Attard 1992), with no statistically significant differences being found among the groups being compared (RR 0.77, 95% CI [0.23 ‐ 2.54]).

Discussion

Eight trials fulfilled the selection criteria and were included in this study. These contribute 922 patients, a number that seems reduced to us given the high prevalence that AAP represents as a cause of consultation in ED. In general terms, it is possible to mention that the methodological quality of the studies included is good, but heterogeneous.

This review shows that the administration of opioid analgesics as part of the diagnostic process for patients with AAP prior to a decision being made did not increase the risk of making unsuitable treatment decisions; it also significantly improved the patient’s comfort when comparing it with the placebo.

No information was found relating to whether the administration of opioids increases the time of clinical evaluation or if a delay occurs in the decision‐making with respect to surgery. As a result, it is not possible to determine for this study the costs involved.

In relation to the hospital stay, this was scarcely reported; and it is only possible to mention that there are not differences in the times of hospitalisation in patients who received opioid analgesics in comparison with those who received a placebo.

A systematic review was found on the subject (Ranji 2006), which used 9 Randomized Controlled Trials. We excluded two of these: one for having used sublingual buprenorphine as the analgesic (Zoltie 1986); and the other for having used intravenous fentanyl as the analgesic and for failure to specify the characteristics of the population in the study (Garyfallou 1997). There is also a narrative review (McHale 2001) that do not establishes definitive conclusions and only suggest that it is safe and humane to administer opioid analgesics to patients with AAP that require emergency attention and that do not have any contraindications for their use.

In general terms, there are sufficient data in this review to suggest that the use of opioid analgesics in patients with AAP does not increase the risk of inadequate treatment decisions; and indeed, it significantly improves the patient’s comfort level, while the diagnostic process if brought to a conclusion.

Authors' conclusions

Implications for practice.

Some evidence indicates that the use of opioid analgesics in patients with AAP, in addition to improving their comfort while the diagnostic process is concluded, does not increase the risk of diagnosis error or the risk of error in decisions for treatment. However, this review is not attempting to recommend any analgesic regime in particular.

Implications for research.

More high‐quality clinical trials are needed to establish the most effective treatment protocols. The included studies are in generally adequate to answer the questions; however, some methodological issues make it imperfect (different research objectives, small sample size and inadequate randomisation). Thus, primary studies require a common objective, an adequate sample size estimation and proper use of random assignment of study subjects. These are the methodological details that can determine that the final conclusion is inappropriate, truthful and non‐reliable. In this case, the results suggest that “the use of opioid analgesics in the therapeutic diagnosis of patients with AAP does not increase the risk of diagnosis error or the risk of error in making decisions regarding treatment”, but if the primary studies were less heterogeneous and had a larger number of in study subjects, it is possible that the end result was different; for example that “the non use of opioid analgesics in the therapeutic diagnosis of patients with AAP does increase the risk of diagnosis error or the risk of error in making decisions regarding treatment” (this, based on the trend observed in the graphs of meta‐analysis).

What's new

Date Event Description
16 June 2010 New citation required but conclusions have not changed Two RCT has been added to the review

History

Protocol first published: Issue 1, 2006
 Review first published: Issue 3, 2007

Date Event Description
23 July 2008 Amended Converted to new review format.
8 May 2007 New citation required and conclusions have changed Substantive amendment

Acknowledgements

The authors wish to thank the external reviewers from the Cochrane Colorectal Cancer Group and the Iberoamerican Cochrane Centre for the collaboration provided to develop this review.

Data and analyses

Comparison 1. Acute abdominal pain.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Intensity of pain (VAS pretreatment) 8 922 Mean Difference (IV, Random, 95% CI) 0.12 [‐0.01, 0.26]
2 Intensity of pain (VAS pretreatment) according to type of opioid 8 922 Mean Difference (IV, Fixed, 95% CI) 0.12 [‐0.01, 0.26]
2.1 Morphine 6 756 Mean Difference (IV, Fixed, 95% CI) 0.10 [‐0.04, 0.24]
2.2 Tramadol 1 66 Mean Difference (IV, Fixed, 95% CI) 0.68 [‐0.04, 1.40]
2.3 Papaveretum 1 100 Mean Difference (IV, Fixed, 95% CI) 0.20 [‐0.65, 1.05]
3 Change in patient comfort level (dicotomic) 1 100 Risk Ratio (M‐H, Random, 95% CI) 0.05 [0.01, 0.19]
4 Change in patient comfort level (continous) 1 48 Mean Difference (IV, Random, 95% CI) ‐2.1 [‐3.00, ‐1.20]
5 Change in intensity of the pain 8 922 Mean Difference (IV, Random, 95% CI) 0.00 [‐2.89, ‐1.10]
5.1 Morphine 6 756 Mean Difference (IV, Random, 95% CI) ‐1.93 [‐2.82, ‐1.03]
5.2 Tramadol 1 66 Mean Difference (IV, Random, 95% CI) ‐0.09 [‐0.81, 0.63]
5.3 Papaveretum 1 100 Mean Difference (IV, Random, 95% CI) ‐5.20 [‐6.91, ‐3.49]
6 Change in physical exploration 5 328 Risk Ratio (M‐H, Random, 95% CI) 1.23 [0.69, 2.20]
6.1 Morfina 4 262 Risk Ratio (M‐H, Random, 95% CI) 1.29 [0.38, 4.36]
6.2 Tramadol 1 66 Risk Ratio (M‐H, Random, 95% CI) 1.27 [0.68, 2.38]
7 Errors in making decision about treatment 3 488 Risk Ratio (M‐H, Random, 95% CI) 0.77 [0.23, 2.54]
8 Treatment error according to type of opiod 3 488 Risk Ratio (M‐H, Random, 95% CI) 0.77 [0.23, 2.54]
8.1 Morfin 2 388 Risk Ratio (M‐H, Random, 95% CI) 1.19 [0.63, 2.27]
8.2 Papaveretum 1 100 Risk Ratio (M‐H, Random, 95% CI) 0.33 [0.07, 1.57]
9 Incorrect diagnosis 6 786 Risk Ratio (M‐H, Random, 95% CI) 0.86 [0.57, 1.29]
10 Incorrect diagnosis according to type of opiod 6 786 Risk Ratio (M‐H, Fixed, 95% CI) 0.85 [0.62, 1.19]
10.1 Morfin 5 686 Risk Ratio (M‐H, Fixed, 95% CI) 0.96 [0.68, 1.35]
10.2 Papaveretum 1 100 Risk Ratio (M‐H, Fixed, 95% CI) 0.22 [0.05, 0.98]
11 Morbidity 4 581 Risk Ratio (M‐H, Random, 95% CI) 5.14 [0.26, 103.37]
11.1 Morfine 3 481 Risk Ratio (M‐H, Random, 95% CI) 5.14 [0.26, 103.37]
11.2 Papaveretum 1 100 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
12 Hospital stay 1 100 Mean Difference (IV, Random, 95% CI) ‐1.0 [‐1.52, ‐0.48]
13 Accurate management decisions 3 488 Risk Ratio (M‐H, Random, 95% CI) 0.77 [0.23, 2.54]
13.1 Morfin 2 388 Risk Ratio (M‐H, Random, 95% CI) 1.19 [0.63, 2.27]
13.2 Papaveretum 1 100 Risk Ratio (M‐H, Random, 95% CI) 0.33 [0.07, 1.57]

1.1. Analysis.

1.1

Comparison 1 Acute abdominal pain, Outcome 1 Intensity of pain (VAS pretreatment).

1.2. Analysis.

1.2

Comparison 1 Acute abdominal pain, Outcome 2 Intensity of pain (VAS pretreatment) according to type of opioid.

1.3. Analysis.

1.3

Comparison 1 Acute abdominal pain, Outcome 3 Change in patient comfort level (dicotomic).

1.4. Analysis.

1.4

Comparison 1 Acute abdominal pain, Outcome 4 Change in patient comfort level (continous).

1.5. Analysis.

1.5

Comparison 1 Acute abdominal pain, Outcome 5 Change in intensity of the pain.

1.6. Analysis.

1.6

Comparison 1 Acute abdominal pain, Outcome 6 Change in physical exploration.

1.7. Analysis.

1.7

Comparison 1 Acute abdominal pain, Outcome 7 Errors in making decision about treatment.

1.8. Analysis.

1.8

Comparison 1 Acute abdominal pain, Outcome 8 Treatment error according to type of opiod.

1.9. Analysis.

1.9

Comparison 1 Acute abdominal pain, Outcome 9 Incorrect diagnosis.

1.10. Analysis.

1.10

Comparison 1 Acute abdominal pain, Outcome 10 Incorrect diagnosis according to type of opiod.

1.11. Analysis.

1.11

Comparison 1 Acute abdominal pain, Outcome 11 Morbidity.

1.12. Analysis.

1.12

Comparison 1 Acute abdominal pain, Outcome 12 Hospital stay.

1.13. Analysis.

1.13

Comparison 1 Acute abdominal pain, Outcome 13 Accurate management decisions.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Amoli 2008.

Methods Randomized double‐blind controlled trial
Participants Patients over 14 years who presented to the ED with clinical signs of acute appendicitis
Interventions Patients scheduled were randomised to receive 0.1 mg/kg morphine (n=35) sulphate or saline 0.9% (n=36) to a maximum dose of 10 mg over a 5 min period.
Outcomes Pain intensity using a visual analogue scale (VAS) and signs of acute appendicitis.
Notes  

Attard 1992.

Methods Randomized double‐blind controlled trial
Participants 100 patients over 16 years with clinically significant abdominal pain who were admitted as emergencies to a surgical firm
Interventions Papaveretum (20 mg) or placebo (normal saline made up to an equal volume) 50 patients to each group
Outcomes Pain and tenderness scores, assessment of patient comfort, accuracy of diagnosis and management decisions
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear

Gallagher 2006.

Methods Randomized double‐blind controlled trial
Participants Patients were eligible if they were 21 years or older, had atraumatic abdominal pain of less than 48 hours’ duration, and were judged by the ED attending physician to warrant opioid analgesia for pain control
Interventions Patients were randomised to receive 0.1 mg/kg morphine intravenously up to a maximum of 10 mg (n=78), or an equal volume of normal saline solution administered as a single intravenous bolus (n=75).
Outcomes The primary endpoint was the difference between the 2 study arms in clinically important diagnostic accuracy
Notes  

LoVecchio 1997.

Methods Randomized double‐blind controlled trial
Participants 48 patients over 18 years admitted to emergency department with acute abdominal pain
Interventions Morphine 5mg (13 patients), morphine10 mg (19 patients) or placebo (normal saline made up to an equal volume) (16 patients)
Outcomes Changes in localization and tenderness, pain measure by VAS
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate

Mahadevan 2000.

Methods Randomized double‐blind controlled trial
Participants 66 patients over 16 years with right lower quadrant pain less than a week's duration (non traumatic in origin) suggestive of acute appendicitis
Interventions Tramadol (1 mg/Kg) or placebo (normal saline made up to an equal volume) 33 patients to each group
Outcomes Absence or presence of seven abdominal signs in predicting for appendicitis (tenderness on light and deep palpation, tenderness in RLQ and elsewhere, rebound, cough and percussion tenderness) and pain measure by VAS
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate

Pace 1996.

Methods Randomized double‐blind controlled trial
Participants 71 patients over 18 years abdominal pain for = 48 hours evolution
Interventions Morphine 10 mg (35 patients) or placebo (normal saline made up to an equal volume) (36 patients)
Outcomes VAS pain level, changes at physical examination, accuracy of diagnosis
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate

Thomas 2003a.

Methods Randomized double‐blind controlled trial
Participants 74 patients over 18 years with undifferentiated abdominal pain of less than 72 hours duration
Interventions Morphine 15 mg (38 patients) or placebo (normal saline made up to an equal volume) (36 patients)
Outcomes VAS pain level, diagnostic accuracy, changes in diagnostic signs
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate

Vermeulen 1999.

Methods Randomized double‐blind controlled trial
Participants 340 patients over 16 years who consulted the emergency department for pain in the right lower part of the abdomen
Interventions Morphine 10 mg (175 patients) or placebo (normal saline made up to an equal volume) (165 patients)
Outcomes VAS pain level, final diagnosis, diagnostic accuracy, appropriateness of the decision to operate
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear

Characteristics of excluded studies [ordered by study ID]

Study Reason for exclusion
Al‐Waili 1998 Use of non‐opioid analgesia regime (non‐steroidal anti‐inflammatory drug)
Alshehri 1995 Diagnostic test design about the value of rebound tenderness as a clinical diagnostic tool in the diagnosis of acute appendicitis 
 Non use of any analgesia regime
Anderson 2000 Diagnostic test design about identify systematic errors in surgeons' estimations of the importance of diagnostic variables in the decision to explore patients with suspected appendicitis 
 Non use of any analgesia regime
Bailey 2007 Use of paediatric population
Cardall 2004 Diagnostic test design about assess the discriminatory value of the total WBC count and presenting body temperature in patients presenting to the emergency department with signs and symptoms suggestive of appendicitis
Champault 1993 Diagnostic test design about conventional diagnostic approach versus primary laparoscopy in women with non‐specific abdominal pain 
 Non use of any analgesia regime
Chaudhary 1999 Use of non‐opioid analgesia regime (combination of antispasmodic analgesic)
Chong 2004 This study used a retrospective chart review design
Clarke 1991 Decision tree study about a model of the surgical decision 
 Non use of any analgesia regime
Clère 2002 Editorial
de los Santos 1999 Use of non‐opioid analgesia regime about the efficacy and tolerance of propinox
Decadt 1999 RCT of the use of early laparoscopy for acute non‐specific abdominal pain 
 Non use of any analgesia regime
Eskelinen 1995 Diagnostic test design about the value of history‐taking, physical examination, and computer assistance in the diagnosis of acute appendicitis in patients more than 50 years old 
 Non use of any analgesia regime
Franke 2002 Cases series about compared two histopathological examinations for the diagnosis of neurogenic appendicopathy 
 Non use of any analgesia regime
Frei 2008 Case‐control study
Furyk 2008 A retrospective chart review of adults and children
Gaitan 2002 Diagnostic test design about the accuracy of laparoscopy and the conventional method based on clinical observation in the etiological diagnosis of non‐specific acute lower abdominal pain in women of reproductive age 
 Non use of any analgesia regime
Gallagher 2002 Diagnostic test design about assess the validity and reliability of the visual analog scale in the measurement of acute abdominal pain 
 Non use of any analgesia regime
Garyfallou 1997 Abstract from an Annual Meeting. Subjects characteristics not reported. Full text not available.
Graff 2000 Diagnostic test design about false‐negative and false‐positive errors in abdominal pain evaluation 
 Non use of any analgesia regime
Green 2005 Early analgesia for children with acute abdominal pain (a type of population study)
Hong 2003 RCT about clinical assessment versus computed tomography for the diagnosis of acute appendicitis 
 Non use of any analgesia regime
Kim 2002 RCT in children with acute abdominal pain (a type of population study)
Kokki 2005 RCT in children with acute abdominal pain (a type of population study)
Lane 1997 Diagnostic test design about a useful sign for the diagnosis of peritoneal irritation in the right iliac fossa 
 Non use of any analgesia regime
Lee 2000 Abscence of results in treatment and non‐treatment groups. Prospective, observational study
Marinsek 2007 Prospective, observational cohort study to examine current practice of analgesia in adults with acute abdominal pain
McHale 2001 Review article about narcotic analgesia in patients with acute abdominal pain
Milojevic 2001 Multicenter prospective survey to measure and describe frecuence of severe acute pain any origin management in emergency departments 
 Non use of any analgesia regime
Mittal 2004 Diagnostic test design about advantages of focused helical computed tomographic scanning with rectal contrast only vs triple contrast in the diagnosis of clinically uncertain acute appendicitis 
 Non use of any analgesia regime
Ng 2002 RCT for the use of CT in patients with acute abdominal pain of unknown cause 
 Non use of any analgesia regime
Niederau 1999 Use of non‐opiod analgesia regime on upper abdominal pain due to functional disorders of the biliary system
Nik Hisamuddin 2008 Prospective observational study involving the use of questionnaires to compare acute pain management and pain relief among ethnic groups
Nissman 2003 A telephone survey of emergency medicine physicians to assess the current practices and opinions regarding the early administration of narcotic analgesia.
Obermaier 2003 Diagnostic test design about the value of ultrasound in the diagnosis of acute appendicitis 
 Non use of any analgesia regime
Orr 1995 Decision tree study about ultrasonography to evaluate adults for appendicitis 
 Non use of any analgesia regime
Oruc 2004 Diagnostic test design about The value of 5‐hydroxy indole acetic acid measurement in spot urine in diagnosis of acute appendicitis 
 Non use of any analgesia regime
Ranji 2006 Design. Systematic review
Rettenbacher 2002 Diagnostic test design about diagnostic imaging is required if the clinical presentation suggests acute appendicitis with high probability 
 Non use of any analgesia regime
Sarfati 1993 Diagnostic test design about impact of adjunctive testing on the diagnosis and clinical course of patients with acute appendicitis 
 Non use of any analgesia regime
Soda 2001 Diagnostic test design about the efficacy of ultrasonography for the diagnosis of acute appendicitis 
 Non use of any analgesia regime
Steiner 2009 Randomized, double‐blind, placebo controlled clinical trials of single‐doses of aspirin 1000 mg in the treatment of acute migraine attacks, episodic tension‐type headache and dental pain.
Tait 1999 Descriptive study about surgical practice for any analgesia administration in patients with acute abdominal pain
Terasawa 2004 Systematic review about the diagnostic accuracy of computed tomography and ultrasonography in adults and adolescents with suspected acute appendicitis 
 Non use of any analgesia regime
Thomas 1999 Correlational study about patient and physician agreement on abdominal pain severity and need for opioid analgesia 
 Non use of any analgesia regime
van Dalen 2003 Diagnostic test design about the utility of laparoscopy in the diagnosis of acute appendicitis in women of reproductive age 
 Non use of any analgesia regime
Vane 2005 Editorial
Vermeulen 1995 Diagnostic test design about the influence of white cell count on surgical decision making in patients with abdominal pain in the right lower quadrant 
 Non use of any analgesia regime
Wolfe 2000 Descriptive study about the current practice patterns of analgesia administration among emergency physicians when caring for a patient with an acute abdomen
Wolfe 2004 Abscence of results in treatment and non‐treatment groups
Zoltie 1986 Clinical trial in patients with acute abdomen but without hard measure outcomes

Contributions of authors

Manterola, Carlos ‐ Critical analysis of articles, protocol and review writing and data collection 
 Vial, Manuel ‐ Critical analysis of articles, protocol and review writing and data collection 
 Astudillo, Paula ‐ Critical analysis of articles, protocol writing 
 Moraga, Javier ‐ Data collection

Sources of support

Internal sources

  • Universidad de La Frontera, Chile.

    Partially financed by project DI09‐0060 of the Office of Research at the Universidad de La Frontera, Temuco, Chile.

External sources

  • No sources of support supplied

Declarations of interest

None Known.

Edited (no change to conclusions)

References

References to studies included in this review

Amoli 2008 {published data only}

  1. Amoli HA, Golozar A, Keshavarzi S, Tavakoli H, Yaghoobi A. Morphine analgesia in patients with acute appendicitis: A randomised double‐blind clinical trial.. Emergency Medicine Journal 2008;25(9):586‐589. [DOI] [PubMed] [Google Scholar]

Attard 1992 {published data only}

  1. Attard AR, Corlett MJ, Kidner NJ, Leslie AP, Fraser IA. Safety of early pain relief for acute abdominal pain. BMJ 1992;305(6853):554‐556. [MEDLINE: ] [DOI] [PMC free article] [PubMed] [Google Scholar]

Gallagher 2006 {published data only}

  1. Gallagher EJ, Esses D, Lee C, Lahn M, Bijur PE. Randomized clinical trial of morphine in acute abdominal pain.. Ann Emerg Med 2006;48(2):150‐160.. [DOI] [PubMed] [Google Scholar]

LoVecchio 1997 {published data only}

  1. LoVecchio F, Oster N, Sturmann K, Nelson LS, Flashner S, Finger R. The use of analgesics in patients with acute abdominal pain. J Emerg Med 1997;15(6):775‐779. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Mahadevan 2000 {published data only}

  1. Mahadevan M, Graff L. Prospective randomized study of analgesic use for ED patients with right lower quadrant abdominal pain. Am J Emerg Med 2000;18(7):753‐756. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Pace 1996 {published data only}

  1. Pace S, Burke TF. Intravenous morphine for early pain relief in patients with acute abdominal pain. Acad Emerg Med 1996;3(12):1086‐1092. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Thomas 2003a {published data only}

  1. Thomas SH, Silen W, Cheema F, Reisner A, Aman S, Goldstein JN, Kumar AM, Stair TO. Effects of morphine analgesia on diagnostic accuracy in Emergency Department patients with abdominal pain: a prospective, randomized trial. J Am Coll Surg 2003;196(1):18‐31. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Vermeulen 1999 {published data only}

  1. Vermeulen B, Morabia A, Unger PF, Goehring C, Grangier C, Skljarov I, Terrier F. Acute appendicitis: influence of early pain relief on the accuracy of clinical and US findings in the decision to operate‐‐a randomized trial. Radiology 1999;210(3):639‐643. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

References to studies excluded from this review

Al‐Waili 1998 {published data only}

  1. Al‐Waili N, Saloom KY. The analgesic effect of intravenous tenoxicam in symptomatic treatment of biliary colic: a comparison with hyoscine N‐butylbromide. Eur J Med Res 1998;3(10):475‐479. [MEDLINE: ] [PubMed] [Google Scholar]

Alshehri 1995 {published data only}

  1. Alshehri MY, Ibrahim A, Abuaisha N, Malatani T, Abu‐Eshy S, Khairulla S, Bahamdan K. Value of rebound tenderness in acute appendicitis. East Afr Med J 1995;72(8):504‐506. [MEDLINE: ] [PubMed] [Google Scholar]

Anderson 2000 {published data only}

  1. Andersson RE, Hugander AP, Ghazi SH, Ravn H, Offenbartl SK, Nystrom PO, Olaison GP. Why does the clinical diagnosis fail in suspected appendicitis?. Eur J Surg 2000;166(10):796‐802. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Bailey 2007 {published data only}

  1. Bailey B, Bergeron S, Gravel J, Bussieres JF, Bensoussan A. Efficacy and Impact of Intravenous Morphine Before Surgical Consultation in Children With Right Lower Quadrant Pain Suggestive of Appendicitis: A Randomized Controlled Trial.. Annals of Emergency Medicine 2007;50(4):371‐378. [DOI] [PubMed] [Google Scholar]

Cardall 2004 {published data only}

  1. Cardall T, Glasser J, Guss DA. Clinical value of the total white blood cell count and temperature in the evaluation of patients with suspected appendicitis. Acad Emerg Med 2004;11(10):1021‐1027. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Champault 1993 {published data only}

  1. Champault G, Rizk N, Lauroy J, Olivares P, Belhassen A, Boutelier P. Right iliac fossa pain in women. Conventional diagnostic approach versus primary laparoscopy. A controlled study (65 cases). Ann Chir 1993;47(4):316‐319. [MEDLINE: ] [PubMed] [Google Scholar]

Chaudhary 1999 {published data only}

  1. Chaudhary A, Gupta RL. Double blind, randomised, parallel, prospective, comparative, clinical evaluation of a combination of antispasmodic analgesic Diclofenac + Pitofenone + Fenpiverinium (Manyana) vs Analgin + Pitofenone + Fenpiverinium (Baralgan) in biliary, ureteric and intestinal colic. J Indian Med Assoc 1999;97(2):72‐75. [MEDLINE: ] [PubMed] [Google Scholar]

Chong 2004 {published data only}

  1. Chong CF, Wang TL, Chen CC, Ma HP, Chang H. Preconsultation use of analgesics on adults presenting to the emergency department with acute appendicitis.. Emerg Med J 2004;21(1):41‐43.. [DOI] [PMC free article] [PubMed] [Google Scholar]

Clarke 1991 {published data only}

  1. Clarke JR, Badawy SB. Acute pain over the appendix. A model of the surgical decision. Ann Chir 1991;45(4):279‐283. [MEDLINE: ] [PubMed] [Google Scholar]

Clère 2002 {published data only}

  1. Clère F, Soriot‐Thomas S. Acute abdominal pain... should be relieved rapidly! [La douleur adbominale aiguë: un mal à combattre .... rapidement !]. Presse Med. 2002 Sep 14;31(29):1348‐9. [MEDLINE: ] [PubMed] [Google Scholar]

de los Santos 1999 {published data only}

  1. Santos AR, Marti ML, Girolamo G, Diego Espinosa J, Morano MA, Tobar JC, Prete C. Propinox in biliary colic: a multicenter, randomized, prospective and parallel double‐blind study of three doses of propinox versus placebo in acute biliary colic pain. Int J Tissue React 1999;21(1):13‐18. [MEDLINE: ] [PubMed] [Google Scholar]

Decadt 1999 {published data only}

  1. Decadt B, Sussman L, Lewis MP, Secker A, Cohen L, Rogers C, Patel A, Rhodes M. Randomized clinical trial of early laparoscopy in the management of acute non‐specific abdominal pain. Br J Surg 1999;86(11):1383‐1386. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Eskelinen 1995 {published data only}

  1. Eskelinen M, Ikonen J, Lipponen P. The value of history‐taking, physical examination, and computer assistance in the diagnosis of acute appendicitis in patients more than 50 years old. Scand J Gastroenterol 1995;30(4):349‐355. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Franke 2002 {published data only}

  1. Franke C, Gerharz CD, Bohner H, Ohmann C, Heydrich G, Kramling HJ, Stock W, Rosen D, Kurpreugsch K, Roher HD. Neurogenic appendicopathy: a clinical disease entity?. Int J Colorectal Dis 2002;17(3):185‐191. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Frei 2008 {published data only}

  1. Frei SP, Bond WF, Bazuro RK, Richardson DM, Sierzega GM, Wasser TE. Is early analgesia associated with delayed treatment of appendicitis?. American Journal of Emergency Medicine 2008;26(2):176‐180. [DOI] [PubMed] [Google Scholar]

Furyk 2008 {published data only}

  1. Furyk J, Sumner M. Pain score documentation and analgesia: A comparison of children and adults with appendicitis.. Emergency Medicine Australasia 2008;20(6):482‐487. [DOI] [PubMed] [Google Scholar]

Gaitan 2002 {published data only}

  1. Gaitan H, Angel E, Sanchez J, Gomez I, Sanchez L, Agudelo C. Laparoscopic diagnosis of acute lower abdominal pain in women of reproductive age. Int J Gynaecol Obstet 2002;76(2):149‐158. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Gallagher 2002 {published data only}

  1. Gallagher EJ, Bijur PE, Latimer C, Silver W. Reliability and validity of a visual analog scale for acute abdominal pain in the ED. Am J Emerg Med 2002;20(4):287‐290. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Garyfallou 1997 {published and unpublished data}

  1. Garyfallou GT, Grillo A, O’Connor RE, Fulda GJ, Levine BJ. A controlled trial of fentanyl analgesia in emergency department patients with abdominal pain:can treatment obscure the diagnosis? [abstract]. Acad Emerg Med 1997;4:424. [Google Scholar]

Graff 2000 {published data only}

  1. Graff L, Russell J, Seashore J, Tate J, Elwell A, Prete M, Werdmann M, Maag R, Krivenko C, Radford M. False‐negative and false‐positive errors in abdominal pain evaluation: failure to diagnose acute appendicitis and unnecessary surgery. Acad Emerg Med 2000;7(11):1244‐1255. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Green 2005 {published data only}

  1. Green R, Bulloch B, Kabani A. Early analgesia for children with acute abdominal pain.. Pediatrics 2005;116:978‐983.. [DOI] [PubMed] [Google Scholar]

Hong 2003 {published data only}

  1. Hong JJ, Cohn SM, Ekeh AP, Newman M, Salama M, Leblang SD. Miami Appendicitis Group. A prospective randomized study of clinical assessment versus computed tomography for the diagnosis of acute appendicitis. Surg Infect (Larchmt) 2003;4(3):231‐239. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Kim 2002 {published data only}

  1. Kim MK, Strait RT, Sato TT, Hennes HM. A randomized clinical trial of analgesia in children with acute abdominal pain. Acad Emerg Med 2002;9(4):281‐287. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Kokki 2005 {published data only}

  1. Kokki H, Lintula H, Vanamo K, Heiskanen M, Eskelinen M. Oxycodone versus placebo inchildren with undifferentiated abdominal pain.. Arch Pediat Adolesc Med 2005;159:320‐325. [DOI] [PubMed] [Google Scholar]

Lane 1997 {published data only}

  1. Lane R, Grabham J. A useful sign for the diagnosis of peritoneal irritation in the right iliac fossa. Ann R Coll Surg Engl 1997;79(2):128‐129. [MEDLINE: ] [PMC free article] [PubMed] [Google Scholar]

Lee 2000 {published data only}

  1. Lee JS, Stiell IG, Wells GA, Elder BR, Vandemheen K, Shapiro S. Adverse outcomes and opioid analgesic administration in acute abdominal pain. Acad Emerg Med 2000;7(9):980‐987. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Marinsek 2007 {published data only}

  1. Marinsek M, Kovacic D, Versnik D, Parasuh M, Golez S, Podbregar M. Analgesic treatment and predictors of satisfaction with analgesia in patients with acute undifferentiated abdominal pain. European Journal of Pain 2007;11(7):773‐778.. [DOI] [PubMed] [Google Scholar]

McHale 2001 {published data only}

  1. McHale PM, LoVecchio F. Narcotic analgesia in the acute abdomen‐‐a review of prospective trials. Eur J Emerg Med 2001;8(2):131‐136. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Milojevic 2001 {published data only}

  1. Milojevic K, Cantineau JP, Simon L, Bataille S, Ruiz R, Coudert B, Simon N, Lambert Y, Groupe Dassy. Acute severe pain in emergencies. The key for efficient analgesia. Ann Fr Anesth Reanim 2001;20(9):745‐751. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Mittal 2004 {published data only}

  1. Mittal VK, Goliath J, Sabir M, Patel R, Richards BF, Alkalay I, ReMine S, Edwards M. Advantages of focused helical computed tomographic scanning with rectal contrast only vs triple contrast in the diagnosis of clinically uncertain acute appendicitis: a prospective randomized study. Arch Surg 2004;139(5):495‐499. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Ng 2002 {published data only}

  1. Ng CS, Watson CJ, Palmer CR, See TC, Beharry NA, Housden BA, Bradley JA, Dixon AK. Evaluation of early abdominopelvic computed tomography in patients with acute abdominal pain of unknown cause: prospective randomised study. BMJ 2002;325:1387. [MEDLINE: ] [DOI] [PMC free article] [PubMed] [Google Scholar]

Niederau 1999 {published data only}

  1. Niederau C, Gopfert E. The effect of chelidonium‐ and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo‐controlled double‐blind study. Med Klin (Munich) 1999;94(8):425‐430. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Nik Hisamuddin 2008 {published data only}

  1. Nik Hisamuddin NAR, Kamaruddin J, Idzwan ZM, Rashidi A. Comparison of acute pain relief, after intravenous morphine administration, among different ethnic groups who presented with acute abdominal pain in the Emergency Department.. Journal of Emergency Medicine, Trauma and Acute Care 2008;8(2):73‐77.. [Google Scholar]

Nissman 2003 {published data only}

  1. Nissman SA, Kaplan LJ, Mann BD. Critically reappraising the literature‐driven practice of analgesia administration for acute abdominal pain in the emergency room prior to surgical evaluation.. Am J Surg 2003;185(4):291‐296.. [DOI] [PubMed] [Google Scholar]

Obermaier 2003 {published data only}

  1. Obermaier R, Benz S, Asgharnia M, Kirchner R, Hopt UT. Value of ultrasound in the diagnosis of acute appendicitis: interesting aspects. Eur J Med Res 2003;8(10):451‐456. [MEDLINE: ] [PubMed] [Google Scholar]

Orr 1995 {published data only}

  1. Orr RK, Porter D, Hartman D. Ultrasonography to evaluate adults for appendicitis: decision making based on meta‐analysis and probabilistic reasoning. Acad Emerg Med 1995;2(7):644‐650. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Oruc 2004 {published data only}

  1. Oruc MT, Kulah B, Ozozan O, Ozer V, Kulacoglu H, Turhan T, Coskun F. The value of 5‐hydroxy indole acetic acid measurement in spot urine in diagnosis of acute appendicitis. East Afr Med J 2004;81(1):40‐41. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Ranji 2006 {published data only}

  1. Ranji SR, Goldman LE, Simel DL, Shojania KG. Do opiates affect the clinical evaluation of patients with acute abdominal pain?. JAMA 2006;296(14):1764‐1774.. [DOI] [PubMed] [Google Scholar]

Rettenbacher 2002 {published data only}

  1. Rettenbacher T, Hollerweger A, Gritzmann N, Gotwald T, Schwamberger K, Ulmer H, Nedden DZ. Appendicitis: should diagnostic imaging be performed if the clinical presentation is highly suggestive of the disease?. Gastroenterology 2002;123(4):992‐998. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Sarfati 1993 {published data only}

  1. Sarfati MR, Hunter GC, Witzke DB, Bebb GG, Smythe SH, Boyan S, Rappaport WD. Impact of adjunctive testing on the diagnosis and clinical course of patients with acute appendicitis. Am J Surg 1993;166(6):660‐664. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Soda 2001 {published data only}

  1. Soda K, Nemoto K, Yoshizawa S, Hibiki T, Shizuya K, Konishi F. Detection of pinpoint tenderness on the appendix under ultrasonography is useful to confirm acute appendicitis. Arch Surg 2001;136(10):1136‐1140. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Steiner 2009 {published data only}

  1. Steiner TJ, Voelker M. Gastrointestinal tolerability of aspirin and the choice of over‐the‐counter analgesia for short‐lasting acute pain.. Journal of Clinical Pharmacy and Therapeutics 2009;34(2):177‐186.. [DOI] [PubMed] [Google Scholar]

Tait 1999 {published data only}

  1. Tait IS, Ionescu MV, Cuschieri A. Do patients with acute abdominal pain wait unduly long for analgesia?. J R Coll Surg Edinb 1999;44(3):181‐184. [MEDLINE: ] [PubMed] [Google Scholar]

Terasawa 2004 {published data only}

  1. Terasawa T, Blackmore CC, Bent S, Kohlwes RJ. Systematic review: computed tomography and ultrasonography to detect acute appendicitis in adults and adolescents. Ann Intern Med 2004;141(7):537‐546. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Thomas 1999 {published data only}

  1. Thomas SH, Borczuk P, Shackelford J, Ostrander J, Silver D, Evans M, Stein J. Patient and physician agreement on abdominal pain severity and need for opioid analgesia. Am J Emerg Med 1999;17(6):586‐590. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

van Dalen 2003 {published data only}

  1. Dalen R, Bagshaw PF, Dobbs BR, Robertson GM, Lynch AC, Frizelle FA. The utility of laparoscopy in the diagnosis of acute appendicitis in women of reproductive age. Surg Endosc 2003;17(8):1311‐1313. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Vane 2005 {published data only}

  1. Vane DW. Abdominal pain efficacy and concerns regarding early analgesia in children with acute abdominal pain.. Pediatrics 2005;116:1018.. [DOI] [PubMed] [Google Scholar]

Vermeulen 1995 {published data only}

  1. Vermeulen B, Morabia A, Unger PF. Influence of white cell count on surgical decision making in patients with abdominal pain in the right lower quadrant. Eur J Surg 1995;161(7):483‐486. [MEDLINE: ] [PubMed] [Google Scholar]

Wolfe 2000 {published data only}

  1. Wolfe JM, Lein DY, Lenkoski K, Smithline HA. Analgesic administration to patients with an acute abdomen: a survey of emergency medicine physicians. Am J Emerg Med 2000;18(3):250‐253. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Wolfe 2004 {published data only}

  1. Wolfe JM, Smithline HA, Phipen S, Montano G, Garb JL, Fiallo V. Does morphine change the physical examination in patients with acute appendicitis?. Am J Emerg Med 2004;22(4):280‐285. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Zoltie 1986 {published data only}

  1. Zoltie N, Cust MP. Analgesia in the acute abdomen [Analgesia in the acute abdomen]. Ann R Coll Surg Engl 1986 Jul;68(4):209‐10. [MEDLINE: ] [PMC free article] [PubMed] [Google Scholar]

Additional references

Ahn 2002

  1. Ahn SH, Mayo‐Smith WW, Murphy BL, Reinert SE, Cronan JJ. Acute nontraumatic abdominal pain in adult patients: Abdominal radiography compared with CT evaluation. Radiology 2002;225:159‐164. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Camus‐Kerebel 1996

  1. Camus‐Kerebel C, Malledant Y, Joly A. Abdominal syndromes and analgesia. Can Anesthesiol 1996;44:335‐9. [MEDLINE: ] [PubMed] [Google Scholar]

Jadad 1996

  1. Jadad AR, Moore RA, Carrol D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? [Assessing the quality of reports of randomized clinical trials: is blinding necessary?]. Controlled Clin Trials 1996;17:1‐12. [DOI] [PubMed] [Google Scholar]

Kim 2003

  1. Kim MK, Galustyan S, Sato TT, Bergholte J, Hennes HM. Analgesia for Children With Acute Abdominal Pain: A Survey of Pediatric Emergency Physicians and Pediatric Surgeons. Pediatrics 2003;112:1122‐26. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Mahler 2004

  1. Mahler CW, Boermeester MA, Stoker J, Obertop H, Gouma DJ. Diagnostic modalities in diagnosis of adult patients with acute abdominal pain. Ned Tijdschr Geneeskd 2004;11(148):2474‐2480. [MEDLINE: ] [PubMed] [Google Scholar]

Stone 1998

  1. Stone R. Acute abdominal pain. Lippincotts Primary Care Practice 1998;2:341‐357. [MEDLINE: ] [PubMed] [Google Scholar]

Thomas 2003

  1. Thomas SH, Silen W. Effect on diagnostic efficiency of analgesia for undifferentiated abdominal pain. British Journal of Surgery 2003;90:5‐9. [MEDLINE: ] [DOI] [PubMed] [Google Scholar]

Articles from The Cochrane Database of Systematic Reviews are provided here courtesy of Wiley

RESOURCES